NIAID Site Search

Last Reviewed: March 31, 2025

The NIAID Adjuvant Webinar Series is a monthly virtual presentation given on current research relating to vaccine adjuvants. Each month a new speaker is invited to share their findings with the adjuvant research community. The overall goals of the webinar series are to publicize recent developments in the adjuvant field and to encourage collaboration between adjuvant researchers. Webinars take

Last Reviewed: March 25, 2025

Dengue fever is an infectious disease carried by mosquitoes and caused by any of four related dengue viruses. This disease used to be called "break-bone" fever because it sometimes causes severe joint and muscle pain that feels like bones are breaking. Health experts have known about dengue fever for more than 200 years. 

Last Reviewed: September 13, 2024

Eric O. Long, Ph.D., is the Chief of the Molecular and Cellular Immunology Section. The main interest of our lab has been the molecular basis of the regulation of human natural killer (NK) cell function in the context of different stimuli and the contribution of activating and inhibitory receptors to intracellular signals that dictate NK cell reactivity.

Last Reviewed: June 23, 2022

Last Reviewed: August 6, 2024

Last Reviewed: August 6, 2024

Last Reviewed: August 6, 2024

Last Reviewed: August 6, 2024

Last Reviewed: August 6, 2024

Last Reviewed: August 6, 2024

Last Reviewed: August 6, 2024

January 30, 2022, marks the third World Neglected Tropical Diseases (NTDs) Day, presenting an opportunity to reflect both on the continuing burden imposed by these diseases and the significant progress made to curtail them. NTDs comprise viral, bacterial, fungal and parasitic diseases that, despite their various causes, have in common their substantial health, social and economic impacts

Published: January 28, 2022

Last Reviewed: August 6, 2024

Last Reviewed: August 6, 2024

Last Reviewed: August 6, 2024

NIAID funds research on disorders that are related to, or occur alongside, food allergy which may offer insight on treatment and prevention.

Last Reviewed: September 16, 2024

Complications arise when the immune system does not function properly. Some issues are less pervasive, such as pollen allergy, while others are extensive, such as genetic disorders that wipe out the presence or function of an entire set of immune cells.

Last Reviewed: January 17, 2014

Sample application from Emily Troemel, Ph.D., for NIH standard independent research project grant (R01).

Last Reviewed: October 11, 2024

FDA has approved omalizumab for the reduction of allergic reactions, including anaphylaxis, that may occur with an accidental exposure to one or more foods in adults and children aged 1 year and older with food allergy. People taking omalizumab still need to avoid exposure to foods to which they are allergic.

Published: February 16, 2024

Over the summer, two postdoc alumni of NIAID’s Laboratory of Immune System Biology returned to NIH (virtually) to share how NIH career development resources shaped their careers. Federica La Russa, Ph.D., and Trisha Tucholski, Ph.D., served as speakers on the Science and Health Policy Alumni Panel organized by the NIH Science Policy Discussion Group (SPDG). Both former co-chairs of the SPDG, Drs. La Russa and Tucholski reflect on how their current careers were positively impacted by their leadership experiences with the policy group.

Published: September 29, 2023

Sample application from David Al-Adra MD, Ph.D., for NIH standard independent research project grant (K08).

Last Reviewed: September 13, 2024

Genetic Delivery of Monoclonal Antibodies for Prevention and Cure of HIV

Last Reviewed: August 12, 2019

Last Reviewed: August 6, 2024

Last Reviewed: August 6, 2024

Last Reviewed: August 6, 2024